Published 13 May 2020
Introduction
In recent weeks, at least seven class action lawsuits have
been filed in federal district courts throughout the United
States against the government of the People's Republic of China
(the "P.R.C." or "China"), all relating to China's alleged
liability for damages and injuries sustained in the ongoing
COVID-19 pandemic. Although plaintiffs in these lawsuits make
broadly different claims, they all face the same highly
formidable legal roadblock: a need to find exceptions that can
pierce the presumptive immunity afforded to China and other
sovereign nations under the Foreign Sovereign Immunities Act
("FSIA"), 28 U.S.C. § 1602, et seq., which would
otherwise preclude their claims at the outset for lack of
jurisdiction.
To read this article you need to be a subscriber
Subscribe
Fill in the registration form and answer a few simple questions to receive a quote.
Subscribe now
Suggested Citation
M. Diaz, Jr.; M. Colomar-Garcia; B.C. Hadaway; G.E. Davidson; X.J. Zhao; J. Coronado; Z. Pan (2020, forthcoming) "The Façade of COVID-19 Class Action Litigation Against China Under the Foreign Sovereign Immunities Act"
(TDM, ISSN 1875-4120) May 2020, www.transnational-dispute-management.com
Other recently published material:
The Power of Investment Arbitral Tribunals to Enjoin Domestic Criminal Proceedings
25 April 2024
Summary of the OGEMID Symposium "Corruption in/on International Arbitration" (January/February 2024)
24 April 2024
Young-OGEMID Author Interview #6: Prof. Dr. Xandra Kramer Prof. Dr. and Laura Carballo Piñeiro (March 2024)
23 April 2024
The Validity of Arbitral Awards and the Public Policy Nature of International Sanctions
11 March 2024
Now available "Climate Change Arbitration: Using the Energy Charter Treaty to Enforce the New European Green Deal" - TDM 1 (2024)
8 March 2024
Complete listing of Advance publication.